Michael Haller is Professor and Chief of Pediatric Endocrinology at the University of Florida. His work focuses on the prediction, prevention, and reversal of beta cell decline in type 1 diabetes. He has served as the study PI for the pediatric inhaled insulin PK/PD studies as well as the RCT for the use of inhaled insulin in children with diabetes.